Jushi Holdings (JUSHF) Gross Margin (2021 - 2026)

Jushi Holdings' (JUSHF) quarterly Gross Margin came in at 44.97% in Q1 2026, up 460.0% year-on-year from 8.03% in Q1 2025, and up 7.41% on a QoQ basis from 41.87% in Q4 2025.

Jushi Holdings (JUSHF) Gross Margin (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has 6 years of Gross Margin data on file, last reported at 44.97% in Q1 2026.

  • On a quarterly basis, Gross Margin rose 460.0% year-over-year to 44.97% in Q1 2026; TTM through Mar 2026 was 44.48%, a 81.0% increase from a year earlier, with the FY2025 full-year figure at 43.35%, down 259.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 44.97%, up from 41.87% in the prior quarter.
  • Over the last five years, Gross Margin for JUSHF reached as high as 50.42% in Q2 2024 and fell as low as 28.58% in Q4 2022.
  • Historically, Gross Margin has averaged 41.71% across 5 years, with a median of 42.85% in 2023.
  • Across the five-year window, Gross Margin jumped 1197 bps in 2023 and tumbled 902 bps in 2025, its largest moves.
  • Year by year, Gross Margin stood at 28.58% in 2022, then surged by 41 bps to 40.16% in 2023, then slipped by 4 bps to 38.58% in 2024, then grew by 9 bps to 41.87% in 2025, then rose by 7 bps to 44.97% in 2026.
  • Per Business Quant data, the three most recent Gross Margin figures were 44.97% in Q1 2026, 41.87% in Q4 2025, and 46.69% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 49.52%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 71.66%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 62.93%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 82.93%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.97%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 98.31%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.26%
10 Jushi Holdings 81.25 Mn 41.54 Mn 29.88 Mn 44.97%

Historic Data

Download Data
DateValue
Mar 31, 2026 44.97%
Dec 31, 2025 41.87%
Sep 30, 2025 46.69%
Jun 30, 2025 44.47%
Mar 31, 2025 40.37%
Dec 31, 2024 38.58%
Sep 30, 2024 45.44%
Jun 30, 2024 50.42%
Mar 31, 2024 49.39%
Dec 31, 2023 40.16%
Sep 30, 2023 43.61%
Jun 30, 2023 46.00%
Mar 31, 2023 42.85%
Dec 31, 2022 28.58%
Sep 30, 2022 38.10%
Jun 30, 2022 36.65%
Mar 31, 2022 30.88%
Dec 31, 2021 29.91%
Sep 30, 2021 43.21%
Jun 30, 2021 45.28%